LINC-ROR and colorectal carcinoma: Li and his colleagues uncovered that linc-ROR exerted its oncogenic role through negatively regulating the expression of miR-6833-3p during the progression of CRC, which might give new insights into molecular diagnosis and treatment (Li et al., 2020a).